The laboratory carries out preclinical development of innovative dosage forms, including those based on liposomal technologies.
A full cycle of work on the development of nanoformulations based on promising medicinal substances proposed by the real sector of the economy, including:
The team of the created laboratory has experience in performing custom research for enterprises from the real sector of the economy.
Selection and synthesis of candidate compounds
Selection of promising candidate medicinal substances (according to the requests of industrial partners). Preparation of substances (chemical modification, biomodification, etc.) and their conversion into a form suitable for incorporation into nanoscale delivery vehicles
Development of scalable (up to pilot production scales) methods of synthesis and optimization of nanoscale delivery vehicles (including liposomes and lipid nanoparticles) suitable for delivery to given physiological targets
Conducting full-scale studies of the behavior of nanoformulations in vitro
Fine organic and bioorganic synthesis
Synthesis of nanoparticles with a given set of properties
Instrumental Methods for Analyzing the Physicochemical and Colloidal Chemical Characteristics of Nanoparticles